CRISPR Gene Therapy Nexiguran Ziclumeran Shows Promise in Early-Stage Study of ATTR Amyloidosis With Polyneuropathy
Key Sessions and Real-World Case Learning at PNS 2025: Kathrin Doppler, MD; Vincent Timmerman, PhD, MSc
AMX0035 Continues Promise in Wolfram Syndrome, FDA Clears Testing for CAP-002, Gene Therapy AAV-GAD Gains RMAT Designation
NeurologyLive® Friday 5 — May 16, 2025